EPX

 

Full name: eosinophil peroxidase Alias Symbol: EPO|EPP|EPX-PEN
Type: protein-coding gene Cytoband: 17q22
Entrez ID: 8288 HGNC ID: HGNC:3423 Ensembl Gene: ENSG00000121053 OMIM ID: 131399
Drug and gene relationship at DGIdb

 

Expression of EPX:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 EPX 8288 214627_at 0.0284 0.9350
GSE20347 EPX 8288 214627_at 0.0306 0.7603
GSE23400 EPX 8288 214627_at -0.1124 0.0145
GSE26886 EPX 8288 214627_at 0.1234 0.2385
GSE29001 EPX 8288 214627_at -0.0589 0.7037
GSE38129 EPX 8288 214627_at -0.0569 0.5775
GSE45670 EPX 8288 214627_at 0.1394 0.1207
GSE53622 EPX 8288 143811 -0.3138 0.0144
GSE53624 EPX 8288 143811 -0.2572 0.0054
GSE63941 EPX 8288 214627_at 0.3425 0.0381
GSE77861 EPX 8288 214627_at -0.0436 0.7646
TCGA EPX 8288 RNAseq -0.2939 0.5572

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by EPX expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of EPX:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 EPX 8288 5 1 24
GSE20123 EPX 8288 5 1 24
GSE43470 EPX 8288 4 0 39
GSE46452 EPX 8288 32 0 27
GSE47630 EPX 8288 7 1 32
GSE54993 EPX 8288 2 5 63
GSE54994 EPX 8288 8 6 39
GSE60625 EPX 8288 4 0 7
GSE74703 EPX 8288 4 0 32
GSE74704 EPX 8288 4 1 15
TCGA EPX 8288 26 8 62

Total number of gains: 101; Total number of losses: 23; Total Number of normals: 364.  


 

Somatic mutations of EPX:

 

Generating mutation plots.

 

Highly correlated genes for EPX:

 

Showing top 20/1257 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
EPXLINC006420.757056303
EPXADM20.744769606
EPXG6PC20.734901404
EPXGAD20.728179404
EPXP2RX60.724531505
EPXC60.715567404
EPXTAAR20.713948404
EPXMAPK150.713139303
EPXGSX10.711648303
EPXCELF30.70787706
EPXUSP290.706186404
EPXADCYAP10.705013303
EPXNPTXR0.704809404
EPXEDA2R0.70183505
EPXNTNG10.697242404
EPXATF70.695447404
EPXSLC6A50.695123404
EPXJAK30.694494606
EPXGIGYF10.694376303
EPXLINC013390.692248303

For details and further investigation, click here